메뉴 건너뛰기




Volumn 64, Issue 3, 2012, Pages 397-406

Clinical outcomes in psoriatic arthritis: A systematic literature review

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; ENTHESITIS; EVIDENCE BASED MEDICINE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW (TOPIC);

EID: 84859854627     PISSN: 00043591     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21552     Document Type: Review
Times cited : (48)

References (108)
  • 1
    • 14244269341 scopus 로고    scopus 로고
    • Psoriatic arthritis assessment tools in clinical trials
    • Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005;64 Suppl:49-54.
    • (2005) Ann Rheum Dis , vol.64 , Issue.SUPPL. , pp. 49-54
    • Mease, P.J.1    Antoni, C.E.2    Gladman, D.D.3    Taylor, W.J.4
  • 2
    • 0346458589 scopus 로고    scopus 로고
    • Assessment of patients with psoriatic arthritis: A review of currently available measures [review]
    • Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthritis: a review of currently available measures [review]. Arthritis Rheum 2004;50:24-35.
    • (2004) Arthritis Rheum , vol.50 , pp. 24-35
    • Gladman, D.D.1    Helliwell, P.2    Mease, P.J.3    Nash, P.4    Ritchlin, C.5    Taylor, W.6
  • 4
    • 67349108364 scopus 로고    scopus 로고
    • The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov
    • Scoggins JF, Patrick DL. The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials 2009;30:289-92.
    • (2009) Contemp Clin Trials , vol.30 , pp. 289-292
    • Scoggins, J.F.1    Patrick, D.L.2
  • 5
    • 58949093097 scopus 로고    scopus 로고
    • Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review
    • Kalyoncu U, Dougados M, Daures JP, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009;68:183-90.
    • (2009) Ann Rheum Dis , vol.68 , pp. 183-190
    • Kalyoncu, U.1    Dougados, M.2    Daures, J.P.3    Gossec, L.4
  • 6
    • 34248648440 scopus 로고    scopus 로고
    • Patient perspective: Fatigue as a recommended patient centered outcome measure in rheumatoid arthritis
    • Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7.
    • (2007) J Rheumatol , vol.34 , pp. 1174-1177
    • Kirwan, J.R.1    Minnock, P.2    Adebajo, A.3    Bresnihan, B.4    Choy, E.5    De Wit, M.6
  • 7
    • 0141506945 scopus 로고    scopus 로고
    • Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001
    • Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003;6:522-31.
    • (2003) Value Health , vol.6 , pp. 522-531
    • Acquadro, C.1    Berzon, R.2    Dubois, D.3    Leidy, N.K.4    Marquis, P.5    Revicki, D.6
  • 9
    • 0034060583 scopus 로고    scopus 로고
    • Learning from discordance in patient and physician global assessment of systemic lupus erythematosus disease activity
    • Neville C, Clarke EA, Joseph L, Belisle P, Ferland D, Fortin PR. Learning from discordance in patient and physician global assessment of systemic lupus erythematosus disease activity. J Rheumatol 2000;27:675-9.
    • (2000) J Rheumatol , vol.27 , pp. 675-679
    • Neville, C.1    Clarke, E.A.2    Joseph, L.3    Belisle, P.4    Ferland, D.5    Fortin, P.R.6
  • 10
    • 0028245607 scopus 로고
    • Comparison between self-reported measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia
    • Hidding A, Van Santen M, De Klerk E, Gielen X, Boers M, Geenen R, et al. Comparison between self-reported measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 1994;21:818-23.
    • (1994) J Rheumatol , vol.21 , pp. 818-823
    • Hidding, A.1    Van Santen, M.2    De Klerk, E.3    Gielen, X.4    Boers, M.5    Geenen, R.6
  • 11
    • 0037229712 scopus 로고    scopus 로고
    • The Stanford Health Assessment Questionnaire (HAQ): A review of its history, issues, progress, and documentation
    • Bruce B, Fries JF. The Stanford Health Assessment Questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78.
    • (2003) J Rheumatol , vol.30 , pp. 167-178
    • Bruce, B.1    Fries, J.F.2
  • 12
    • 34247599336 scopus 로고    scopus 로고
    • Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning
    • Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum 2007;57:487-94.
    • (2007) Arthritis Rheum , vol.57 , pp. 487-494
    • Stamm, T.A.1    Nell, V.2    Mathis, M.3    Coenen, M.4    Aletaha, D.5    Cieza, A.6
  • 14
    • 77955365567 scopus 로고    scopus 로고
    • United States National Institutes of Health (NIH)
    • United States National Institutes of Health (NIH). Understanding clinical trials. 2007. URL: http://clinicaltrials.gov/ ct2/info/understand.
    • (2007) Understanding Clinical Trials
  • 16
    • 0032527564 scopus 로고    scopus 로고
    • Effect of blinding and unmasking on the quality of peer review: A randomized trial
    • Van Rooyen S, Godlee F, Evans S, Smith R, Black N. Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA 1998;280:234-7.
    • (1998) JAMA , vol.280 , pp. 234-237
    • Van Rooyen, S.1    Godlee, F.2    Evans, S.3    Smith, R.4    Black, N.5
  • 18
    • 77953181751 scopus 로고    scopus 로고
    • Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis
    • Mease PJ, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou CF. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. J Rheumatol 2010;37:1221-7.
    • (2010) J Rheumatol , vol.37 , pp. 1221-1227
    • Mease, P.J.1    Woolley, J.M.2    Singh, A.3    Tsuji, W.4    Dunn, M.5    Chiou, C.F.6
  • 19
    • 76149102966 scopus 로고    scopus 로고
    • Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial
    • Sterry W, Ortonne JP, Kirkham B, Brocq O, Robertson D, Pedersen RD, et al. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial. BMJ 2010;340: c147.
    • (2010) BMJ , vol.340
    • Sterry, W.1    Ortonne, J.P.2    Kirkham, B.3    Brocq, O.4    Robertson, D.5    Pedersen, R.D.6
  • 20
    • 77950860194 scopus 로고    scopus 로고
    • Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease- modifying antirheumatic drugs
    • Atteno M, Peluso R, Costa L, Padula S, Lervolino S, Caso F, et al. Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease- modifying antirheumatic drugs. Clin Rheumatol 2010; 29:399-403.
    • (2010) Clin Rheumatol , vol.29 , pp. 399-403
    • Atteno, M.1    Peluso, R.2    Costa, L.3    Padula, S.4    Lervolino, S.5    Caso, F.6
  • 21
    • 65249137637 scopus 로고    scopus 로고
    • Golimumab, a new human tumor necrosis factor antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four- week efficacy and safety results of a randomized, placebocontrolled study
    • [published erratum appears in Arthritis Rheum 2010;62:2555]
    • Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, et al. Golimumab, a new human tumor necrosis factor antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four- week efficacy and safety results of a randomized, placebocontrolled study [published erratum appears in Arthritis Rheum 2010;62:2555]. Arthritis Rheum 2009;60:976-86.
    • (2009) Arthritis Rheum , vol.60 , pp. 976-986
    • Kavanaugh, A.1    McInnes, I.2    Mease, P.3    Krueger, G.G.4    Gladman, D.5    Gomez-Reino, J.6
  • 22
    • 60249084148 scopus 로고    scopus 로고
    • Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, doubleblind, placebo-controlled, crossover trial
    • Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, doubleblind, placebo-controlled, crossover trial. Lancet 2009;373: 633-40.
    • (2009) Lancet , vol.373 , pp. 633-640
    • Gottlieb, A.1    Menter, A.2    Mendelsohn, A.3    Shen, Y.K.4    Li, S.5    Guzzo, C.6
  • 23
    • 54449083958 scopus 로고    scopus 로고
    • Effects of a modular behavioural arthritis education programme: A pragmatic parallelgroup randomized controlled trial
    • Hammond A, Bryan J, Hardy A. Effects of a modular behavioural arthritis education programme: a pragmatic parallelgroup randomized controlled trial. Rheumatology (Oxford) 2008;47:1712-8.
    • (2008) Rheumatology (Oxford) , vol.47 , pp. 1712-1718
    • Hammond, A.1    Bryan, J.2    Hardy, A.3
  • 24
    • 67651233979 scopus 로고    scopus 로고
    • A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: Effects of adalimumab treatment on synovial tissue
    • Van Kuijk AW, Gerlag DM, Vos K, Wolbink G, de Groot M, de Rie MA, et al. A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue. Ann Rheum Dis 2009;68:1303-9.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1303-1309
    • Van Kuijk, A.W.1    Gerlag, D.M.2    Vos, K.3    Wolbink, G.4    De Groot, M.5    De Rie, M.A.6
  • 25
    • 44349113958 scopus 로고    scopus 로고
    • Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: Findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT
    • Antoni CE, Kavanaugh A, van der Heijde D, Beutler A, Keenan G, Zhou B, et al. Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). J Rheumatol 2008;35: 869-76.
    • (2008) J Rheumatol , vol.35 , pp. 869-876
    • Antoni, C.E.1    Kavanaugh, A.2    Van Der Heijde, D.3    Beutler, A.4    Keenan, G.5    Zhou, B.6
  • 26
    • 45049085438 scopus 로고    scopus 로고
    • The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: Results of a pilot randomized 6-month trial with methotrexate
    • Scarpa R, Peluso R, Atteno M, Manguso F, Spano A, Iervolino S, et al. The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomized 6-month trial with methotrexate. Clin Rheumatol 2008;27:823-6.
    • (2008) Clin Rheumatol , vol.27 , pp. 823-826
    • Scarpa, R.1    Peluso, R.2    Atteno, M.3    Manguso, F.4    Spano, A.5    Iervolino, S.6
  • 27
    • 36348982256 scopus 로고    scopus 로고
    • A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis
    • Kivitz AJ, Espinoza LR, Sherrer YR, Liu-Dumaw M, West CR. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis. Semin Arthritis Rheum 2007;37:164-73.
    • (2007) Semin Arthritis Rheum , vol.37 , pp. 164-173
    • Kivitz, A.J.1    Espinoza, L.R.2    Sherrer, Y.R.3    Liu-Dumaw, M.4    West, C.R.5
  • 28
    • 34248653725 scopus 로고    scopus 로고
    • Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy
    • Genovese MC, Mease PJ, Thomson GT, Kivitz AJ, Perdok RJ, Weinberg MA, et al. Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. J Rheumatol 2007;34:1040-50.
    • (2007) J Rheumatol , vol.34 , pp. 1040-1050
    • Genovese, M.C.1    Mease, P.J.2    Thomson, G.T.3    Kivitz, A.J.4    Perdok, R.J.5    Weinberg, M.A.6
  • 29
    • 34447344038 scopus 로고    scopus 로고
    • Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: A 12-month open randomized pilot study
    • Saviola G, Abdi AL, Shams ES, Coppini A, Cavalieri F, Campostrini L, et al. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study. Rheumatology (Oxford) 2007; 46:994-8.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 994-998
    • Saviola, G.1    Abdi, A.L.2    Shams, E.S.3    Coppini, A.4    Cavalieri, F.5    Campostrini, L.6
  • 31
    • 33847032894 scopus 로고    scopus 로고
    • Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial
    • Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, et al. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Arthritis Rheum 2007; 56:476-88.
    • (2007) Arthritis Rheum , vol.56 , pp. 476-488
    • Gladman, D.D.1    Mease, P.J.2    Ritchlin, C.T.3    Choy, E.H.4    Sharp, J.T.5    Ory, P.A.6
  • 32
    • 34147204834 scopus 로고    scopus 로고
    • Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: Results from the IMPACT 2 trial
    • Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, et al. Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Ann Rheum Dis 2007;66:498-505.
    • (2007) Ann Rheum Dis , vol.66 , pp. 498-505
    • Kavanaugh, A.1    Krueger, G.G.2    Beutler, A.3    Guzzo, C.4    Zhou, B.5    Dooley, L.T.6
  • 33
    • 33846871057 scopus 로고    scopus 로고
    • Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: Patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
    • Gladman DD, Mease PJ, Cifaldi MA, Perdok RJ, Sasso E, Medich J. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Ann Rheum Dis 2007; 66:163-8.
    • (2007) Ann Rheum Dis , vol.66 , pp. 163-168
    • Gladman, D.D.1    Mease, P.J.2    Cifaldi, M.A.3    Perdok, R.J.4    Sasso, E.5    Medich, J.6
  • 34
    • 33750985674 scopus 로고    scopus 로고
    • Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis
    • Kavanaugh A, Antoni C, Mease P, Gladman D, Yan S, Bala M, et al. Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis. J Rheumatol 2006;33:2254-9.
    • (2006) J Rheumatol , vol.33 , pp. 2254-2259
    • Kavanaugh, A.1    Antoni, C.2    Mease, P.3    Gladman, D.4    Yan, S.5    Bala, M.6
  • 35
    • 60149084054 scopus 로고    scopus 로고
    • And the Alefacept in Psoriatic Arthritis Study Group. Alefacept with methotrexate for treatment of psoriatic arthritis: Open-label extension of a randomized, double-blind, placebo-controlled study
    • Mease PJ, Reich K, and the Alefacept in Psoriatic Arthritis Study Group. Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 2009;60:402-11.
    • (2009) J Am Acad Dermatol , vol.60 , pp. 402-411
    • Mease, P.J.1    Reich, K.2
  • 36
    • 77649220720 scopus 로고    scopus 로고
    • Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies
    • behalf of the British Society for Rheumatology Biologics Register
    • Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL, on behalf of the British Society for Rheumatology Biologics Register. Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies. Arthritis Care Res (Hoboken) 2010;62:345-53.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 345-353
    • Saad, A.A.1    Ashcroft, D.M.2    Watson, K.D.3    Symmons, D.P.4    Noyce, P.R.5    Hyrich, K.L.6
  • 37
    • 66149129631 scopus 로고    scopus 로고
    • Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT
    • Mease PJ, Ory P, Sharp JT, Ritchlin CT, Van den Bosch F, Wellborne F, et al. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis 2009;68:702-9.
    • (2009) Ann Rheum Dis , vol.68 , pp. 702-709
    • Mease, P.J.1    Ory, P.2    Sharp, J.T.3    Ritchlin, C.T.4    Van Den Bosch, F.5    Wellborne, F.6
  • 38
    • 76649113735 scopus 로고    scopus 로고
    • The radiological assessment of axial involvement in psoriatic arthritis: A validation study of the BASRI total and the modified SASSS scoring methods
    • Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, et al. The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Clin Exp Rheumatol 2009;27:977-80.
    • (2009) Clin Exp Rheumatol , vol.27 , pp. 977-980
    • Lubrano, E.1    Marchesoni, A.2    Olivieri, I.3    D'Angelo, S.4    Spadaro, A.5    Parsons, W.J.6
  • 39
    • 72449210551 scopus 로고    scopus 로고
    • Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
    • Mazzotta A, Esposito M, Schipani C, Chimenti S. Long-term experience with etanercept in psoriatic arthritis patients: a 3-year observational study. J Dermatolog Treat 2009;20: 354-8.
    • (2009) J Dermatolog Treat , vol.20 , pp. 354-358
    • Mazzotta, A.1    Esposito, M.2    Schipani, C.3    Chimenti, S.4
  • 40
    • 75749091855 scopus 로고    scopus 로고
    • Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions
    • Van den Bosch F, Manger B, Goupille P, McHugh N, Rodevand E, Holck P, et al. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis 2010;69:394-9.
    • (2010) Ann Rheum Dis , vol.69 , pp. 394-399
    • Van Den Bosch, F.1    Manger, B.2    Goupille, P.3    McHugh, N.4    Rodevand, E.5    Holck, P.6
  • 41
    • 77950302418 scopus 로고    scopus 로고
    • Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate- treated patients with rheumatoid arthritis
    • Lie E, van der Heijde D, Uhlig T, Heiberg MS, Koldingsnes W, Rodevand E, et al. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate- treated patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:671-6.
    • (2010) Ann Rheum Dis , vol.69 , pp. 671-676
    • Lie, E.1    Van Der Heijde, D.2    Uhlig, T.3    Heiberg, M.S.4    Koldingsnes, W.5    Rodevand, E.6
  • 42
    • 69749111953 scopus 로고    scopus 로고
    • International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis
    • Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum 2009;61:1235-42.
    • (2009) Arthritis Rheum , vol.61 , pp. 1235-1242
    • Chandran, V.1    Gottlieb, A.2    Cook, R.J.3    Duffin, K.C.4    Garg, A.5    Helliwell, P.6
  • 43
  • 44
    • 68949148678 scopus 로고    scopus 로고
    • Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study
    • Mazzotta A, Esposito M, Costanzo A, Chimenti S. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Am J Clin Dermatol 2009;10:319-24.
    • (2009) Am J Clin Dermatol , vol.10 , pp. 319-324
    • Mazzotta, A.1    Esposito, M.2    Costanzo, A.3    Chimenti, S.4
  • 45
    • 68149178632 scopus 로고    scopus 로고
    • MonitorNet: The Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice
    • Sfriso P, SalaffiF, Montecucco CM, Bombardieri S, Todesco S. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice. Reumatismo 2009;61: 132-9.
    • (2009) Reumatismo , vol.61 , pp. 132-139
    • Sfriso, P.1    Salaffi, F.2    Montecucco, C.M.3    Bombardieri, S.4    Todesco, S.5
  • 46
    • 67449092887 scopus 로고    scopus 로고
    • Psoriatic Arthritis Spondylitis Radiology Index: A modified index for radiologic assessment of axial involvement in psoriatic arthritis
    • Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, et al. Psoriatic Arthritis Spondylitis Radiology Index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol 2009;36: 1006-11.
    • (2009) J Rheumatol , vol.36 , pp. 1006-1011
    • Lubrano, E.1    Marchesoni, A.2    Olivieri, I.3    D'Angelo, S.4    Spadaro, A.5    Parsons, W.J.6
  • 47
    • 63049126065 scopus 로고    scopus 로고
    • Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: Results of an open, follow-up pilot study
    • Gaal J, Lakos G, Szodoray P, Kiss J, Horvath I, Horkay E, et al. Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm Venereol 2009;89: 140-4.
    • (2009) Acta Derm Venereol , vol.89 , pp. 140-144
    • Gaal, J.1    Lakos, G.2    Szodoray, P.3    Kiss, J.4    Horvath, I.5    Horkay, E.6
  • 48
    • 73449087657 scopus 로고    scopus 로고
    • Effect of adalimumab on joint disease: Features of patients with psoriatic arthritis detected by magnetic resonance imaging
    • Anandarajah AP, Ory P, Salonen D, Feng C, Wong RL, Ritchlin CT. Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging. Ann Rheum Dis 2010;69:206-9.
    • (2010) Ann Rheum Dis , vol.69 , pp. 206-209
    • Anandarajah, A.P.1    Ory, P.2    Salonen, D.3    Feng, C.4    Wong, R.L.5    Ritchlin, C.T.6
  • 49
    • 61349101588 scopus 로고    scopus 로고
    • Health care utilization in patients with spondyloarthropathies
    • Singh JA, Strand V. Health care utilization in patients with spondyloarthropathies. Rheumatology (Oxford) 2009;48: 272-6.
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 272-276
    • Singh, J.A.1    Strand, V.2
  • 50
    • 57449107591 scopus 로고    scopus 로고
    • Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis
    • Bongiorno MR, Pistone G, Doukaki S, Arico M. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis. Dermatol Ther 2008;21 Suppl:S15-20.
    • (2008) Dermatol Ther , vol.21 , Issue.SUPPL.
    • Bongiorno, M.R.1    Pistone, G.2    Doukaki, S.3    Arico, M.4
  • 51
    • 58149350282 scopus 로고    scopus 로고
    • Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: An exploratory analysis from the APHRODITE data
    • Cassano N, Galluccio A, De Simone C, Loconsole F, Massimino SD, Plumari A, et al. Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data. J Biol Regul Homeost Agents 2008;22: 233-7.
    • (2008) J Biol Regul Homeost Agents , vol.22 , pp. 233-237
    • Cassano, N.1    Galluccio, A.2    De Simone, C.3    Loconsole, F.4    Massimino, S.D.5    Plumari, A.6
  • 52
    • 56749178275 scopus 로고    scopus 로고
    • Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids: Clinical efficacy extended to patients on systemic anti-tumour necrosis factor
    • Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids: clinical efficacy extended to patients on systemic anti-tumour necrosis factor. Ann Rheum Dis 2008;67:1787-90.
    • (2008) Ann Rheum Dis , vol.67 , pp. 1787-1790
    • Conti, F.1    Ceccarelli, F.2    Priori, R.3    Iagnocco, A.4    Signore, A.5    Valesini, G.6
  • 53
    • 57349179855 scopus 로고    scopus 로고
    • Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis
    • Leung YY, Tam LS, Lee KW, Leung MH, Kun EW, Li EK. Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis. Rheumatology (Oxford) 2009;48:53-6.
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 53-56
    • Leung, Y.Y.1    Tam, L.S.2    Lee, K.W.3    Leung, M.H.4    Kun, E.W.5    Li, E.K.6
  • 54
    • 54349107274 scopus 로고    scopus 로고
    • Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis
    • Spadaro A, Ceccarelli F, Scrivo R, Valesini G. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis. Ann Rheum Dis 2008;67: 1650-1.
    • (2008) Ann Rheum Dis , vol.67 , pp. 1650-1651
    • Spadaro, A.1    Ceccarelli, F.2    Scrivo, R.3    Valesini, G.4
  • 55
    • 54449096830 scopus 로고    scopus 로고
    • The psoriatic arthritis cost evaluation study: A cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
    • Olivieri de Portu S, Salvarani C, Cauli A, Lubrano E, Spadaro A, et al. The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) 2008;47:1664-70.
    • (2008) Rheumatology (Oxford) , vol.47 , pp. 1664-1670
    • Olivieri De Portu, S.1    Salvarani, C.2    Cauli, A.3    Lubrano, E.4    Spadaro, A.5
  • 56
    • 56249100681 scopus 로고    scopus 로고
    • Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis
    • Holman AJ, Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton Neurosci 2008;143:58-67.
    • (2008) Auton Neurosci , vol.143 , pp. 58-67
    • Holman, A.J.1    Ng, E.2
  • 58
    • 44849131003 scopus 로고    scopus 로고
    • Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs
    • Cantini F, Niccoli L, Nannini C, Cassara E, Pasquetti P, Olivieri I, et al. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second- line drugs. Rheumatology (Oxford) 2008;47:872-6.
    • (2008) Rheumatology (Oxford) , vol.47 , pp. 872-876
    • Cantini, F.1    Niccoli, L.2    Nannini, C.3    Cassara, E.4    Pasquetti, P.5    Olivieri, I.6
  • 59
    • 39449132386 scopus 로고    scopus 로고
    • The comparative oneyear performance of anti-tumor necrosis factor drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study
    • Heiberg MS, Koldingsnes W, Mikkelsen K, Rodevand E, Kaufmann C, Mowinckel P, et al. The comparative oneyear performance of anti-tumor necrosis factor drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthritis Rheum 2008;59: 234-40.
    • (2008) Arthritis Rheum , vol.59 , pp. 234-240
    • Heiberg, M.S.1    Koldingsnes, W.2    Mikkelsen, K.3    Rodevand, E.4    Kaufmann, C.5    Mowinckel, P.6
  • 60
    • 39549105629 scopus 로고    scopus 로고
    • The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis
    • Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, et al. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis. Ann Rheum Dis 2008;67: 296-301.
    • (2008) Ann Rheum Dis , vol.67 , pp. 296-301
    • Anandarajah, A.P.1    Schwarz, E.M.2    Totterman, S.3    Monu, J.4    Feng, C.Y.5    Shao, T.6
  • 61
    • 34848872765 scopus 로고    scopus 로고
    • Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis
    • the CASPAR Study Group
    • Helliwell PS, Porter G, and the CASPAR Study Group. Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis. Skeletal Radiol 2007;36:1061-6.
    • (2007) Skeletal Radiol , vol.36 , pp. 1061-1066
    • Helliwell, P.S.1    Porter, G.2
  • 62
    • 34547937137 scopus 로고    scopus 로고
    • International spondyloarthritis interobserver reliability exercise: The INSPIRE study. II. Assessment of peripheral joints, enthesitis, and dactylitis
    • Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, et al. International spondyloarthritis interobserver reliability exercise: the INSPIRE study. II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007;34:1740-5.
    • (2007) J Rheumatol , vol.34 , pp. 1740-1745
    • Gladman, D.D.1    Inman, R.D.2    Cook, R.J.3    Maksymowych, W.P.4    Braun, J.5    Davis, J.C.6
  • 63
    • 39549105616 scopus 로고    scopus 로고
    • Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group register
    • Kristensen LE, Gulfe A, Saxne T, Geborek P. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register. Ann Rheum Dis 2008;67: 364-9.
    • (2008) Ann Rheum Dis , vol.67 , pp. 364-369
    • Kristensen, L.E.1    Gulfe, A.2    Saxne, T.3    Geborek, P.4
  • 64
    • 34547934676 scopus 로고    scopus 로고
    • International spondyloarthritis interobserver reliability exercise: The INSPIRE study. I. Assessment of spinal measures
    • Gladman DD, Inman RD, Cook RJ, van der Heijde D, Landewe RB, Braun J, et al. International spondyloarthritis interobserver reliability exercise: the INSPIRE study. I. Assessment of spinal measures. J Rheumatol 2007;34:1733-9.
    • (2007) J Rheumatol , Issue.34 , pp. 1733-1739
    • Gladman, D.D.1    Inman, R.D.2    Cook, R.J.3    Van Der Heijde, D.4    Landewe, R.B.5    Braun, J.6
  • 65
    • 34447293977 scopus 로고    scopus 로고
    • Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
    • Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, et al. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. J Am Acad Dermatol 2007;57:269-75.
    • (2007) J Am Acad Dermatol , vol.57 , pp. 269-275
    • Papoutsaki, M.1    Chimenti, M.S.2    Costanzo, A.3    Talamonti, M.4    Zangrilli, A.5    Giunta, A.6
  • 66
    • 34248399606 scopus 로고    scopus 로고
    • Etanercept improves psoriatic arthritis patient-reported outcomes: Results from EDUCATE
    • Frankel EH, Strober BE, Crowley JJ, Fivenson DP, Woolley JM, Yu EB, et al. Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE. Cutis 2007;79:322-6.
    • (2007) Cutis , vol.79 , pp. 322-326
    • Frankel, E.H.1    Strober, B.E.2    Crowley, J.J.3    Fivenson, D.P.4    Woolley, J.M.5    Yu, E.B.6
  • 67
    • 34247226625 scopus 로고    scopus 로고
    • Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: Results from the educate trial
    • Kimball AB, Jackson JM, Sobell JM, Boh EE, Grekin S, Pharmd EB, et al. Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial. J Drugs Dermatol 2007;6:299-306.
    • (2007) J Drugs Dermatol , vol.6 , pp. 299-306
    • Kimball, A.B.1    Jackson, J.M.2    Sobell, J.M.3    Boh, E.E.4    Grekin, S.5    Pharmd, E.B.6
  • 68
    • 34248673265 scopus 로고    scopus 로고
    • Measuring dactylitis in clinical trials: Which is the best instrument to use?
    • Healy PJ, Helliwell PS. Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol 2007;34: 1302-6.
    • (2007) J Rheumatol , vol.34 , pp. 1302-1306
    • Healy, P.J.1    Helliwell, P.S.2
  • 69
    • 34547195862 scopus 로고    scopus 로고
    • The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: A 6 month results from a longitudinal, observational, multicentre study
    • Heiberg MS, Kaufmann C, Rodevand E, Mikkelsen K, Koldingsnes W, Mowinckel P, et al. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: a 6 month results from a longitudinal, observational, multicentre study. Ann Rheum Dis 2007;66: 1038-42.
    • (2007) Ann Rheum Dis , vol.66 , pp. 1038-1042
    • Heiberg, M.S.1    Kaufmann, C.2    Rodevand, E.3    Mikkelsen, K.4    Koldingsnes, W.5    Mowinckel, P.6
  • 71
    • 34147195555 scopus 로고    scopus 로고
    • Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
    • Gratacos J, Casado E, Real J, Torre-Alonso JC. Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate. Ann Rheum Dis 2007;66: 493-7.
    • (2007) Ann Rheum Dis , vol.66 , pp. 493-497
    • Gratacos, J.1    Casado, E.2    Real, J.3    Torre-Alonso, J.C.4
  • 73
    • 33846034460 scopus 로고    scopus 로고
    • Modest but sustained increase in serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab
    • Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, et al. Modest but sustained increase in serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol 2006;33:2440-6.
    • (2006) J Rheumatol , vol.33 , pp. 2440-2446
    • Spanakis, E.1    Sidiropoulos, P.2    Papadakis, J.3    Ganotakis, E.4    Katsikas, G.5    Karvounaris, S.6
  • 75
  • 76
    • 0018099294 scopus 로고
    • Severe psoriasis: Oral therapy with a new retinoid
    • Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
    • (1978) Dermatologica , vol.157 , pp. 238-244
    • Fredriksson, T.1    Pettersson, U.2
  • 77
    • 0021046385 scopus 로고
    • Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
    • Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
    • (1983) Arthritis Rheum , vol.26 , pp. 1346-1353
    • Pincus, T.1    Summey, J.A.2    Soraci Jr., S.A.3    Wallston, K.A.4    Hummon, N.P.5
  • 78
    • 0028579768 scopus 로고
    • A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
    • Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21:2281-5.
    • (1994) J Rheumatol , vol.21 , pp. 2281-2285
    • Calin, A.1    Garrett, S.2    Whitelock, H.3    Kennedy, L.G.4    O'Hea, J.5    Mallorie, P.6
  • 79
    • 0028606163 scopus 로고
    • Functional assessment in ankylosing spondylitis: Evaluation of a new self-administered questionnaire and correlation with anthropometric variables
    • Abbott CA, Helliwell PS, Chamberlain MA. Functional assessment in ankylosing spondylitis: evaluation of a new self-administered questionnaire and correlation with anthropometric variables. Br J Rheumatol 1994;33:1060-6.
    • (1994) Br J Rheumatol , vol.33 , pp. 1060-1066
    • Abbott, C.A.1    Helliwell, P.S.2    Chamberlain, M.A.3
  • 80
    • 0023802883 scopus 로고
    • Assessing disability in patients with rheumatoid arthritis: Use of a Swedish version of the Stanford Health Assessment Questionnaire
    • Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988;17:263-71.
    • (1988) Scand J Rheumatol , vol.17 , pp. 263-271
    • Ekdahl, C.1    Eberhardt, K.2    Andersson, S.I.3    Svensson, B.4
  • 82
    • 0021806804 scopus 로고
    • The visual analogue scale: Its use in pain measurement
    • Langley GB, Sheppeard H. The visual analogue scale: its use in pain measurement. Rheumatol Int 1985;5:145-8.
    • (1985) Rheumatol Int , vol.5 , pp. 145-148
    • Langley, G.B.1    Sheppeard, H.2
  • 83
    • 0027412976 scopus 로고
    • A simple index to assess disease activity in rheumatoid arthritis
    • Scott DL. A simple index to assess disease activity in rheumatoid arthritis. J Rheumatol 1993;20:582-4.
    • (1993) J Rheumatol , vol.20 , pp. 582-584
    • Scott, D.L.1
  • 84
    • 0027153431 scopus 로고
    • Short Form 36 (SF36) health survey questionnaire: Normative data for adults of working age
    • Jenkinson C, Coulter A, Wright L. Short Form 36 (SF36) health survey questionnaire: normative data for adults of working age. Br Med J 1993;306:1437-40.
    • (1993) Br Med J , vol.306 , pp. 1437-1440
    • Jenkinson, C.1    Coulter, A.2    Wright, L.3
  • 85
    • 0028332995 scopus 로고
    • Dermatology Life Quality Index (DLQI), a simple practical measure for routine clinical use
    • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI), a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
    • (1994) Clin Exp Dermatol , vol.19 , pp. 210-216
    • Finlay, A.Y.1    Khan, G.K.2
  • 86
    • 0031872695 scopus 로고    scopus 로고
    • Comparison of the MOS Short Form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis
    • Hurst NP, Ruta DA, Kind P. Comparison of the MOS Short Form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Br J Rheumatol 1998;37: 862-9.
    • (1998) Br J Rheumatol , vol.37 , pp. 862-869
    • Hurst, N.P.1    Ruta, D.A.2    Kind, P.3
  • 87
    • 1642580545 scopus 로고    scopus 로고
    • Development of the PsAQoL: A quality of life instrument specific to psoriatic arthritis
    • McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ, et al. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9.
    • (2004) Ann Rheum Dis , vol.63 , pp. 162-169
    • McKenna, S.P.1    Doward, L.C.2    Whalley, D.3    Tennant, A.4    Emery, P.5    Veale, D.J.6
  • 88
    • 18744368778 scopus 로고    scopus 로고
    • Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis
    • Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005; 32:811-9.
    • (2005) J Rheumatol , vol.32 , pp. 811-819
    • Cella, D.1    Yount, S.2    Sorensen, M.3    Chartash, E.4    Sengupta, N.5    Grober, J.6
  • 89
    • 0028575453 scopus 로고
    • A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
    • Garrett S, Jenkinson T, Kennedy G, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
    • (1994) J Rheumatol , vol.21 , pp. 2286-2291
    • Garrett, S.1    Jenkinson, T.2    Kennedy, G.3    Whitelock, H.4    Gaisford, P.5    Calin, A.6
  • 90
    • 0025688231 scopus 로고
    • EuroQol: A new facility for the measurement of health-related quality of life
    • EuroQol Group
    • EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
    • (1990) Health Policy , vol.16 , pp. 199-208
  • 91
    • 0036169017 scopus 로고    scopus 로고
    • The estimation of a preference- based measure of health from the SF-36
    • Brazier J, Roberts J, Deverill M. The estimation of a preference- based measure of health from the SF-36. J Health Econ 2002;21:271-92.
    • (2002) J Health Econ , vol.21 , pp. 271-292
    • Brazier, J.1    Roberts, J.2    Deverill, M.3
  • 92
    • 57349179855 scopus 로고    scopus 로고
    • Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis
    • Leung YY, Tam LS, Lee KW, Leung MH, Kun EW, Li EK. Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis. Rheumatology (Oxford) 2009;48:53-6.
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 53-56
    • Leung, Y.Y.1    Tam, L.S.2    Lee, K.W.3    Leung, M.H.4    Kun, E.W.5    Li, E.K.6
  • 93
    • 0035191550 scopus 로고    scopus 로고
    • Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE
    • Hewlett S, Cockshott Z, Kirwan J, Barrett J, Stamp J, Haslock I. Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology (Oxford) 2001;40:1221-30.
    • (2001) Rheumatology (Oxford) , vol.40 , pp. 1221-1230
    • Hewlett, S.1    Cockshott, Z.2    Kirwan, J.3    Barrett, J.4    Stamp, J.5    Haslock, I.6
  • 94
    • 0024586813 scopus 로고
    • Development and evaluation of a scale to measure perceived selfefficacy in people with arthritis
    • Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived selfefficacy in people with arthritis. Arthritis Rheum 1989;32: 37-44.
    • (1989) Arthritis Rheum , vol.32 , pp. 37-44
    • Lorig, K.1    Chastain, R.L.2    Ung, E.3    Shoor, S.4    Holman, H.R.5
  • 95
    • 0021891225 scopus 로고
    • The measurement of helplessness in rheumatoid arthritis: The development of the Arthritis Helplessness Index
    • Nicassio PM, Wallston KA, Callahan LF, Herbert M, Pincus T. The measurement of helplessness in rheumatoid arthritis: the development of the Arthritis Helplessness Index. J Rheumatol 1985;12:462-7.
    • (1985) J Rheumatol , vol.12 , pp. 462-467
    • Nicassio, P.M.1    Wallston, K.A.2    Callahan, L.F.3    Herbert, M.4    Pincus, T.5
  • 96
    • 0034253655 scopus 로고    scopus 로고
    • Understanding the adoption of arthritis self-management: Stages of change profiles among arthritis patients
    • Keefe FJ, Lefebvre JC, Kerns RD, Rosenberg R, Beaupre P, Prochaska J, et al. Understanding the adoption of arthritis self-management: stages of change profiles among arthritis patients. Pain 2000;87:303-13.
    • (2000) Pain , vol.87 , pp. 303-313
    • Keefe, F.J.1    Lefebvre, J.C.2    Kerns, R.D.3    Rosenberg, R.4    Beaupre, P.5    Prochaska, J.6
  • 98
    • 20244376625 scopus 로고    scopus 로고
    • Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
    • [published erratum appears in Arthritis Rheum 2005; 52:2951]
    • Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [published erratum appears in Arthritis Rheum 2005;52:2951]. Arthritis Rheum 2005;52:1227-36.
    • (2005) Arthritis Rheum , vol.52 , pp. 1227-1236
    • Antoni, C.E.1    Kavanaugh, A.2    Kirkham, B.3    Tutuncu, Z.4    Burmester, G.R.5    Schneider, U.6
  • 99
    • 33846254645 scopus 로고    scopus 로고
    • The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis
    • Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007;34: 123-9.
    • (2007) J Rheumatol , vol.34 , pp. 123-129
    • Cassell, S.E.1    Bieber, J.D.2    Rich, P.3    Tutuncu, Z.N.4    Lee, S.J.5    Kalunian, K.C.6
  • 100
    • 0036169930 scopus 로고    scopus 로고
    • Guidelines for the management of rheumatoid arthritis: 2002 update
    • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
    • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46:328-46.
    • (2002) Arthritis Rheum , vol.46 , pp. 328-346
  • 101
    • 0028815803 scopus 로고
    • Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
    • Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
    • (1995) Arthritis Rheum , vol.38 , pp. 44-48
    • Prevoo, M.L.1    Van'T Hof, M.A.2    Kuper, H.H.3    Van Leeuwen, M.A.4    Van De Putte, L.B.5    Van Riel, P.L.6
  • 102
    • 2042519830 scopus 로고    scopus 로고
    • Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis: A Department of Veterans Affairs cooperative study
    • Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39:2013-20.
    • (1996) Arthritis Rheum , vol.39 , pp. 2013-2020
    • Clegg, D.O.1    Reda, D.J.2    Mejias, E.3    Cannon, G.W.4    Weisman, M.H.5    Taylor, T.6
  • 103
    • 0030068817 scopus 로고    scopus 로고
    • Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria
    • Van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
    • (1996) Arthritis Rheum , vol.39 , pp. 34-40
    • Van Gestel, A.M.1    Prevoo, M.L.2    Van'T Hof, M.A.3    Van Rijswijk, M.H.4    Van De Putte, L.B.5    Van Riel, P.L.6
  • 104
    • 68849107567 scopus 로고    scopus 로고
    • OMERACT 9: 9th International Consensus Conference on outcome measures in rheumatology clinical trials
    • Tugwell P, Boers M, Strand V, Simon LS, Brooks P, Tugwell P, et al. OMERACT 9: 9th International Consensus Conference on outcome measures in rheumatology clinical trials. J Rheumatol 2009;36:1765-8.
    • (2009) J Rheumatol , vol.36 , pp. 1765-1768
    • Tugwell, P.1    Boers, M.2    Strand, V.3    Simon, L.S.4    Brooks, P.5    Tugwell, P.6
  • 106
    • 70349264142 scopus 로고    scopus 로고
    • Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9
    • Kirwan JR, Newman S, Tugwell PS, Wells GA, Hewlett S, Idzera L, et al. Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. J Rheumatol 2009;36:2071-6.
    • (2009) J Rheumatol , vol.36 , pp. 2071-2076
    • Kirwan, J.R.1    Newman, S.2    Tugwell, P.S.3    Wells, G.A.4    Hewlett, S.5    Idzera, L.6
  • 108
    • 77951600238 scopus 로고    scopus 로고
    • New insights into the experience of fatigue among patients with rheumatoid arthritis: A qualitative study
    • Nikolaus S, Bode C, Taal E, van de Laar MA. New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study. Ann Rheum Dis 2010;69: 895-7.
    • (2010) Ann Rheum Dis , vol.69 , pp. 895-897
    • Nikolaus, S.1    Bode, C.2    Taal, E.3    Van De Laar, M.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.